A blood test that detects circulating tumor DNA (ctDNA) can help guide post-surgical immunotherapy for patients with muscle-invasive bladder cancer. The test identified a benefit in patients with positive ctDNA, who experienced reduced disease recurrence and death risk compared to those without.
A new study by New York University researchers found that the brain processes multiple words at once in a hierarchical manner, similar to a subway system. The brain coordinates different levels of processing, such as sounds, words, and meanings, without interference, allowing for efficient interpretation of speech.
The new agreement between EUROfusion and ITER aims to enhance collaboration in material research, training, and education for the next generation of fusion specialists. Joint initiatives will support ITER's construction and operation, advancing scientific expertise and technological innovation in the global fusion landscape.
The PRIMA device partially restored vision to 27 out of 32 participants in a clinical trial, allowing them to read with acuity equivalent to 20/42 vision. The device works by projecting images onto the retina via infrared light and converting them into electrical stimulation, enabling form vision.
A new study published in PNAS found that physical activity increases total daily energy expenditure without reducing it elsewhere. The research showed a clear link between being more active and spending less time sitting still.
Research from the University of Gothenburg has identified two bacteria that can produce bioactive serotonin, a key player in bowel movements and brain function. These findings suggest new avenues for treating functional gastrointestinal disorders like IBS.
A next-generation coil interface has been developed for efficient and safe non-contact peripheral nerve stimulation, enhancing the treatment of chronic pain and nerve dysfunctions. The breakthrough technology uses magnetic fields to stimulate nerves without direct contact, minimizing scar tissue formation and skin irritation.
The WSU-led team created antennas that remain stable when bent or exposed to high humidity, temperature variations, and salt. They also developed a processor chip that can correct errant signals in real-time.
Dr. Peiro brings extensive expertise in performing delicate, life-saving surgery on babies before and immediately after birth. The center combines expertise in maternal-fetal medicine, genetics, and diagnostics with multidisciplinary pediatric teams to ensure seamless care.
A team of scientists at HIPS has developed a chemo-enzymatic platform to produce large quantities of furanolides, a class of natural products with high structural diversity. The resulting substances have shown promising biological activities against bacterial pathogens and cancer cells.
Karel Svoboda and Jay Shendure have made significant contributions to the advancement of medical sciences, healthcare, and public health. Their work has led to groundbreaking discoveries in cellular imaging, genomics, and synthetic biology.
A new AI-based system automatically detects and tracks river plastics using template matching, YOLOv8, and Deep SORT. This innovation enables continuous monitoring of floating plastics in rivers, distinguishing between types to evaluate source reduction measures.
The new American Gastroenterological Association guideline emphasizes the need for regular monitoring in many patients with Barrett's esophagus who do not exhibit dysplasia or cancerous changes. The guideline also recommends using high-definition white-light endoscopy in combination with chromoendoscopy to improve detection of Barrett'...
A new study found that hormone therapy can alter sex-specific blood proteins in transgender women, resembling those of cisgender women. The therapy may reduce the risk of heart disease and increase the risk of allergic and autoimmune diseases.
Using a new terahertz spectroscopic technique, researchers have revealed that tiny stacks of 2D materials can naturally form cavities, confining light and electrons in even tinier spaces. This discovery could help control quantum phases and ultimately harness them for future quantum technologies.
A new clinical trial by ECOG-ACRIN Cancer Research Group found pembrolizumab reduced cancer recurrence risk to 73% in patients receiving the treatment after surgery. Patients also showed a 42% lower risk of developing distant metastases.
The new report aims to harness the potential of artificial intelligence (AI) in care delivery by modernizing outdated laws, regulations, and payment systems. It highlights promising tools such as ambient documentation, virtual care coordination systems, and personalized clinical education.
A recent study found that 44% of people with chronic conditions experience medication-related burden, which can reduce adherence to treatment and lower quality of life. Healthcare professionals should prioritize patient perspectives and individualized treatment planning to address this issue.
EPFL researchers have discovered a room-temperature version of the Leidenfrost effect, where oil droplets can bounce for up to five minutes on a vibrating solid surface. The phenomenon is driven by the droplet's own deformations, allowing it to perpetually bounce indefinitely.
Eight finalists compete in November for the award, with innovations including non-invasive sleep studies and treatments for obstructive sleep apnea. The AASM's Sleep Medicine Disruptors event will be held in Austin, Texas, on November 14-15.
The Ebbinghaus illusion shows that perception is not a mirror of reality but a construction of the brain. Research on fish and birds reveals diverse perceptual strategies, with guppies closely mirroring human perception and ring doves showing variability in their responses.
The American Heart Association found that nearly 9 in 10 US adults haven't heard of CKM syndrome, a condition affecting heart disease, kidney disease, diabetes, and obesity. The association is providing resources to help people understand the connection between heart, kidney, and metabolic health.
Scientists analyzed thousands of proteins in blood samples to understand when multiple sclerosis attacks the myelin sheath and nerve fibers. Researchers identified a protein called IL-3, which plays a key role in this early phase of damage.
The new guideline recommends clinicians ask about mental health as part of usual care and for patients to discuss it with their providers. The task force did not find evidence that routine screening leads to better mental health.
Researchers at the University of Pittsburgh and UPMC developed a new treatment for patients with drug-resistant epilepsy. The approach uses deep brain stimulation (DBS) targeted to each patient's unique brain wiring, resulting in a significant reduction in seizures, with some patients becoming seizure-free for months.
A new study reveals that combining proteasome inhibitors with Lys05 can effectively kill AML cells by disabling backup survival pathways. This approach has shown promise in preclinical models and could lead to improved treatment options for a wider range of AML patients.
A Tohoku University research team synthesized a high-purity graphene mesosponge that serves as a stable scaffold for loading polymorphic ruthenium catalysts. The study clearly distinguished between carbon cathode degradation and electrolyte decomposition, revealing the 'weakest link' in Li-O2 batteries.
Researchers at NYU Langone Health found that pembrolizumab therapy results in a trend toward improvement in survival rates for patients with Merkel cell carcinoma. After two years, 73% of patients taking pembrolizumab showed no signs of cancer recurrence.
A new international study reveals that nitrogen fixation occurs beneath Arctic sea ice, increasing available nitrogen for algae and potentially boosting marine life. This discovery could also impact carbon absorption in the Arctic Ocean.
A recent study reveals that mercury pollution from artisanal and small-scale gold mining directly contaminates food crops through the air, not soil. This poses a significant risk to human health and food security in Africa, where millions of people depend on local agriculture for survival.
Researchers created microscopic DNA 'flowers' that can change shape and behavior in response to their surroundings. These tiny robots, made from special crystals formed by combining DNA and inorganic materials, can perform tasks on their own, from delivering medicine to cleaning up pollution.
A study published in Pediatrics found that adoption of early peanut introduction guidelines led to significant reductions in diagnosis of peanut and other IgE-mediated food allergies. The findings suggest a promising impact on public health efforts to disseminate these practices.
A recent study published in CANCER found that the number and complexity of cancer clinical trials have varied greatly across low- and middle-income countries (LMICs) since 2001. While economic growth has been a contributing factor, it is not the sole determinant of cancer clinical trial growth among LMICs.
A new study has identified a leptin-sensitive brain circuit in the lateral hypothalamus that helps animals overcome anxiety to perform essential behaviors such as eating, exploring, and limiting maladaptive hyperactivity. Boosting the activity of these neurons can restore adaptive choices even under conditions that cause anxiety.
A team of scientists mapped the magnetic domains on a giant magnetofossil and found that it could sense tiny variations in the Earth's magnetic field, enabling navigation. The discovery suggests that ancient marine organisms may have used a biological compass system.
A new study reveals that most massive stars in the early universe were born as binary systems, similar to those in our own galaxy. This finding provides the first strong evidence for the common existence of massive binary stars in the early universe, shaping black holes and supernovae.
UCLA investigators unveil decade-long survival data for immunotherapy in advanced lung cancer and promising results for novel therapies targeting PSMA, DKK1, and FGFR3 in various aggressive cancers. These breakthroughs hold promise for improved treatment outcomes and quality of life for patients with difficult-to-treat diseases.
Researchers have unveiled the molecular mechanisms underlying L1's retrotransposition and integration into genomic DNA. The study reveals that ORF2p interacts primarily with the DNA backbone through electrostatic forces, enabling site-specific cleavage during retrotransposition.
The Japan Science and Technology Agency hosts an international symposium on weather controllability technologies as part of Moonshot Goal 8. The goal aims to mitigate the effects of extreme weather disasters by 2050 through innovative research and development of weather-control technologies.
Researchers propose a novel analytical model that considers multiple nonlinear factors in motor performance calculation, reducing errors caused by magnetic saturation. The new method significantly improves design efficiency and prediction accuracy, cutting development time and cost.
A research team at DGIST developed a new alloy structure that enhances oxygen reduction reaction efficiency in hydrogen fuel cells. The catalyst, which combines platinum and transition metals with magnetic properties, exceeded durability targets set by the US Department of Energy.
Researchers proposed a four-level modulation strategy for dual three-phase open-winding PMSM drives, achieving higher efficiency and lower current harmonics. The proposed strategy reduces average current THD by more than 29% and switching frequencies by up to 90%.
Researchers at NIT Puducherry unveiled an energy-efficient model predictive current control (MPCC) method that enhances induction motor drive performance in electric vehicles. The CSVVV-based MPCC introduces a novel way to synthesize voltage vectors, reducing switching losses and current ripple.
A team of researchers identified a unique protein signature that can predict which patients are likely to resist standard therapies, paving the way for personalized treatments. By blocking a specific transporter system, they made tumors more sensitive to treatment, suggesting a promising new avenue for treating colorectal cancer.
A team of scientists has created a detailed model of how cells regulate traffic through the nuclear pore complex, revealing that flexible protein chains create an entropic barrier that admits only properly escorted cargo. This breakthrough sheds light on diseases like cancer, Alzheimer's, and ALS, where this transport system fails.
A new control strategy for hybrid magnetic bearing systems is proposed, employing an improved cascaded reduced-order linear active disturbance rejection controller. The strategy significantly enhances rotor suspension stability by employing feedforward compensation, reducing displacement fluctuations and improving system robustness. Ex...
AI accelerates pathogen evolution prediction and enables new target discovery, facilitating efficient compound design and optimization. This technology compresses the development cycle by focusing on key applications like phenotype-driven target identification and validation.
Research reveals that even native ecosystems can't adapt to extreme drought conditions, leading to significant impacts on plant growth and productivity. Productivity declines by up to 77% in four years under consecutive extreme droughts.
A sub-study of KEYMAKER-U03 found pembrolizumab-based triplet combinations to be effective in treating advanced renal cell carcinoma, with an objective response rate of 78% and a median progression-free survival of 31.8 months. The most promising combination included pembrolizumab, belzutifan, and lenvatinib.
Patients receiving mRNA-based COVID vaccines showed improved survival rates and responses to immunotherapy, especially in 'cold' tumors with low PD-L1 expression. The study suggests that these vaccines can reprogram immune responses against cancer, potentially improving outcomes for patients with treatment-resistant disease.
A recent study found that patients with advanced lung and skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine. The observation marks a significant step toward a long-awaited universal cancer vaccine to boost tumor-fighting eff...
The VT3989 trial demonstrated a disease control rate of 86% in refractory mesothelioma patients, with notable partial responses and stable disease. The YAP-TEAD inhibitor also showed an encouraging safety profile, supporting continued clinical development in this unmet clinical need.
A clinical trial showed a new drug combination reduced deaths in patients with recurrent prostate cancer after surgery or radiation therapy. The combination of hormone therapy and enzalutamide cut the risk of death by 40%, offering a meaningful treatment option for high-risk patients.
A new antibody drug conjugate (ADC) sacituzumab govitecan has been shown to improve progression-free survival in patients with advanced triple-negative breast cancer who are ineligible for immune checkpoint inhibitors. The ADC targets the protein Trop2 on TNBC cells and delivers a potent chemotherapy drug directly to tumor sites.
The European Society of Endocrinology has published a new Clinical Practice Guideline for the Management and Evaluation of Menopause and the Perimenopause. The guideline provides guidance on evaluating and managing women with menopause-related symptoms, including hormone therapy benefits and risks. It also discusses alternative treatme...
A novel cofactor engineering approach using phosphite dehydrogenase enables the scalable and efficient biosynthesis of lactate-based copolymers in Escherichia coli. The method yields higher yields of poly(3-hydroxybutyrate-co-lactate) without disrupting bacterial growth, paving the way for sustainable bioplastic manufacturing.
A Phase II clinical trial led by researchers at the University of Texas MD Anderson Cancer Center demonstrated significant tumor shrinkage and disease control in patients with advanced pheochromocytoma and paraganglioma. Belzutifan showed a 26% objective response rate, with sustained clinical benefits for those who responded to treatment.
A phase 3 study found that giredestrant plus everolimus significantly improved progression-free survival in patients with ER-positive, HER-2-negative advanced breast cancer. The treatment combination reduced the risk of disease progression or death by 63% in patients with ESR1 mutations.
A randomized trial found that patients with metastatic clear-cell renal carcinoma lived longer without disease progression when treated with lenvatinib and everolimus compared to cabozantinib. The study suggests that lenvatinib plus everolimus may offer a more meaningful benefit as second-line treatment for these patients.
A new class of anti-cancer agents—antibody-drug conjugates (ADCs)—has unveiled compelling evidence that can dramatically improve outcomes for patients with early-stage HER2-positive breast cancer. The phase III DESTINY-Breast05 and DESTINY-Breast11 trials have shown superior efficacy and improved disease-free survival rates, positionin...